S and Methods Neural progenitor cell culture and conditioned mediumHuman fetal brain Epigenetic Reader Domain tissue (12?6 weeks post-conception) was obtained from elective abortions carried out by the University of Washington in full compliance with the University of Washington, the University of Nebraska Medical Center, and the National Institutes of Health (NIH) ethical guidelines, with human subjects Institutional Review Board (IRB) approval no. 96-1826-A07 (University of Washington) and no. 123-02-FB (University of Nebraska Medical Center). A written informed consent is obtained by the University of Washington using an IRB approved consent 
form. Human cortical NPCs were isolated as 12926553 previously described [19]. NPCs were cultured in substrate-free tissue culture flasks and grown as spheres in neurosphere initiation medium (NPIM), which consists of X-Vivo 15 (BioWhittaker, Walkersville, ME) with N2 supplement (Gibco BRL, Carlsbad, CA), neural cell survival factor-1 (NSF-1, Bio Whittaker), basic fibroblast growth factor (bFGF, 20 ng/ml, Sigma-Aldrich, St. Louis, MO), epidermal growth factor (EGF, 20 ng/ml, Sigma-Aldrich), leukemia inhibitory factor (LIF, 10 ng/ml, Chemicon, Temecula, CA), and Nacetylcysteine (60 ng/ml, Sigma-Aldrich). Cells were passaged at two-week intervals as previously described [19]. To collect conditioned medium, dissociated NPCs were plated on poly-D-lysine-coated cell culture dishes in NPIM for 24 h. Cells were rinsed with fresh X-Vivo 15 and then treated with TNF-a (20 ng/ml) in X-Vivo 15 for 24 h. The NPC conditioned medium (NCM) was then harvested, cleared of free-floating cells by centrifugation for 5 min at 1200 rpm, and stored at 280uC. To block the soluble factors in NCM, it was pre-incubated with neutralizing antibodies for LIF (1 mg/ml, R D Systems, Minneapolis, MN) or IL-6 (1 mg/ml, R D Systems) for 1 h at 37uC. Cells were then treated with NCM 
with or without neutralizing antibodies for 30 min. Whole-cell protein lysates were collected for inhibitor Western blot or cells were fixed for immunocytochemical analysis.Aldrich) 23727046 to identify nuclei. Morphological changes were visualized and captured with a Nikon Eclipse E800 microscope equipped with a digital imaging system. Images were imported into ImageProPlus, version 7.0 (Media Cybernetics, Sliver Spring, MD) for quantification. Ten to fifteen random fields (total 500?000 cells per culture) of immunostained cells were manually counted using a 206 objective.Western blottingCells were rinsed twice with PBS and lysed by M-PER Protein Extraction Buffer (Pierce, Rockford, IL) containing 16 protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN). Protein concentration was determined using a BCA Protein Assay Kit (Pierce). Proteins (20?0 mg) were separated on a 10 SDSpolyacrylamide gel electrophoresis (PAGE) and then transferred to an Immuno-Blot polyvinylidene fluoride (PVDF) membrane (BioRad, Hercules, CA). After blocking in PBS/Tween (0.1 ) with 5 nonfat milk, the membrane was incubated with primary antibodies (phospho- and total-STAT3, Cell Signaling Technologies; b-actin, GFAP, and b-III-tubulin, Sigma-Aldrich) overnight at 4uC followed by horseradish peroxidase-conjugated secondary antibodies (Cell Signaling Technologies, 1:10,000) and then developed using Enhanced Chemiluminescent (ECL) solution (Pierce). For data quantification the films were scanned with a CanonScan 9950F scanner and the acquired images were then analyzed on a Macintosh computer using the public domain NIH i.S and Methods Neural progenitor cell culture and conditioned mediumHuman fetal brain tissue (12?6 weeks post-conception) was obtained from elective abortions carried out by the University of Washington in full compliance with the University of Washington, the University of Nebraska Medical Center, and the National Institutes of Health (NIH) ethical guidelines, with human subjects Institutional Review Board (IRB) approval no. 96-1826-A07 (University of Washington) and no. 123-02-FB (University of Nebraska Medical Center). A written informed consent is obtained by the University of Washington using an IRB approved consent form. Human cortical NPCs were isolated as 12926553 previously described [19]. NPCs were cultured in substrate-free tissue culture flasks and grown as spheres in neurosphere initiation medium (NPIM), which consists of X-Vivo 15 (BioWhittaker, Walkersville, ME) with N2 supplement (Gibco BRL, Carlsbad, CA), neural cell survival factor-1 (NSF-1, Bio Whittaker), basic fibroblast growth factor (bFGF, 20 ng/ml, Sigma-Aldrich, St. Louis, MO), epidermal growth factor (EGF, 20 ng/ml, Sigma-Aldrich), leukemia inhibitory factor (LIF, 10 ng/ml, Chemicon, Temecula, CA), and Nacetylcysteine (60 ng/ml, Sigma-Aldrich). Cells were passaged at two-week intervals as previously described [19]. To collect conditioned medium, dissociated NPCs were plated on poly-D-lysine-coated cell culture dishes in NPIM for 24 h. Cells were rinsed with fresh X-Vivo 15 and then treated with TNF-a (20 ng/ml) in X-Vivo 15 for 24 h. The NPC conditioned medium (NCM) was then harvested, cleared of free-floating cells by centrifugation for 5 min at 1200 rpm, and stored at 280uC. To block the soluble factors in NCM, it was pre-incubated with neutralizing antibodies for LIF (1 mg/ml, R D Systems, Minneapolis, MN) or IL-6 (1 mg/ml, R D Systems) for 1 h at 37uC. Cells were then treated with NCM with or without neutralizing antibodies for 30 min. Whole-cell protein lysates were collected for Western blot or cells were fixed for immunocytochemical analysis.Aldrich) 23727046 to identify nuclei. Morphological changes were visualized and captured with a Nikon Eclipse E800 microscope equipped with a digital imaging system. Images were imported into ImageProPlus, version 7.0 (Media Cybernetics, Sliver Spring, MD) for quantification. Ten to fifteen random fields (total 500?000 cells per culture) of immunostained cells were manually counted using a 206 objective.Western blottingCells were rinsed twice with PBS and lysed by M-PER Protein Extraction Buffer (Pierce, Rockford, IL) containing 16 protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN). Protein concentration was determined using a BCA Protein Assay Kit (Pierce). Proteins (20?0 mg) were separated on a 10 SDSpolyacrylamide gel electrophoresis (PAGE) and then transferred to an Immuno-Blot polyvinylidene fluoride (PVDF) membrane (BioRad, Hercules, CA). After blocking in PBS/Tween (0.1 ) with 5 nonfat milk, the membrane was incubated with primary antibodies (phospho- and total-STAT3, Cell Signaling Technologies; b-actin, GFAP, and b-III-tubulin, Sigma-Aldrich) overnight at 4uC followed by horseradish peroxidase-conjugated secondary antibodies (Cell Signaling Technologies, 1:10,000) and then developed using Enhanced Chemiluminescent (ECL) solution (Pierce). For data quantification the films were scanned with a CanonScan 9950F scanner and the acquired images were then analyzed on a Macintosh computer using the public domain NIH i.
